Position in NKTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,916,571
+$2,268,527 QoQ
Shares Held
3,150,732
0.0% QoQ
Ownership
4.40%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#6
of 136 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GSK plc holds $597,041,457 across 12 Biotechnology names. NKTX ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
3,220,627 | $175,652,996 | |
| 2 | WVE |
Wave Life Sciences, Inc.
|
18,245,691 | $106,007,464 | |
| 3 | VIR |
Vir Biotechnology, Inc.
|
8,550,954 | $87,134,221 | |
| 4 | BNTX |
BioNTech SE
|
889,824 | $82,798,123 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
1,333,333 | $49,693,320 | |
| 6 | CYTK |
Cytokinetics Inc
|
340,434 | $29,001,572 | |
| 7 | LYEL |
Lyell Immunopharma, Inc.
|
1,512,659 | $21,252,858 | |
| 8 | SPRO |
Spero Therapeutics, Inc.
|
9,190,606 | $20,311,239 |
All Filings in NKTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,916,571 | 3,150,732 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,648,044 | 3,150,732 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,828,854 | 3,150,732 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||